Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
1092
result was found. Results
Pilot study of budesonide and montelukast sodium in the treatment of children with bronchial asthma based on interesting respiratory rehabilitation training
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1192-1201.
228 times
95 times
WANG Xuehong
YI Xiaoqin
YUAN Yanhua
Bronchial asthma
Interesting respiratory rehabilitation training
Budesonide
Montelukast sodium
Lung function
Inflammatory factors
Details
The application of the Chinese Drug-Related Problems Classification System in neurology department pharmaceutical care
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1202-1209.
271 times
110 times
GUO Hejian
CHEN Guoquan
ZHU Yalan
CHEN Guangming
CHEN Hongfang
CHEN Gang
Drug-related problems
Chinese Drug-Related Problems Classification System
Department of neurology
Pharmaceutical care
Clinical pharmacist
Details
Establishment and clinical application of standardized management for oral drug administration through nasal feeding
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1210-1219.
285 times
101 times
LIU Yu
CHEN Donglin
HUANG Liyun
WANG Baiqiao
Nasal feeding administration of oral drugs
Management standards
Awareness
Rationality
Evidence-based practice
Details
Data mining research on traditional Chinese medicine formulas for epilepsy treatment based on national patents
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1220-1230.
241 times
101 times
HUANG Haiwen
HU Jiajing
ZHANG Yi
CHEN Shaolan
HUANG Qianqian
GAO Min
Data mining
Epilepsy
Traditional Chinese medicine compound
Medication and compatibility patterns
Wind-expelling and convulsion-arresting drugs
Liver-soothing and wind-extinguishing drugs
Patent
Details
Data-mining of piperacillin-tazobactam related adverse drug event signals based on FAERS
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1231-1239.
239 times
85 times
LIU Jinwei
DONG Junli
SHAO Yu
ZHANG Shaohui
Piperacillin tazobactam
Adverse drug event
FAERS database
Signal mining
Diseases of blood and lymphatic system
Medication safety
Details
Exploring the implementation of licensed assistant pharmacist system in retail pharmacies
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1240-1247.
256 times
110 times
XU Long
YE Hua
YANG Jianwei
WEN Ruirui
ZHU Wenjing
Retail pharmacy
Licensed assistant pharmacist
Pharmacy technicians with secondary vocational education
Pharmaceutical care
Details
Analysis of the factors influencing the efficacy of conventional Western medicine treatment on patients with acute exacerbation of COPD
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1248-1256.
234 times
80 times
GAO Xiaoxue
LI Yanfei
LIU Baozhu
Chronic obstructive pulmonary disease
Conventional treatment
Therapeutic efficacy
Risk factors
Individualized therapy
Logistic regression
Details
Antifibrinolytic drugs used in pediatric cardiac surgery: a systematic review and Meta-analysis
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1257-1264.
274 times
88 times
WANG Qian
LIANG Xingchi
YANG Xinghai
LIU Jun
Cardiac surgery
Extracorporeal circulation
Antifibrinolytic drugs
Peptidase
Tranexamic acid
Aminocaproic acid
Cardiopulmonary
Hemostasis
Safety
Details
Ideological and political teaching design for clinical research curriculum
Published on
Frontiers in Pharmaceutical Sciences
2024,27(7):1265-1272.
276 times
90 times
YAN Siyu
HUANG Jiao
WANG Yu
GUO Yi
ZENG Xiantao
JIN Yinghui
Clinical research
Ideological and political education in curriculum
Medical courses
Simulation teaching
Flipped classroom
Problem-based learning
Case-based learning
Team-based learning
Details
Pharmacoeconomic evaluation of fluticasone furoate/umeclidinium/ vilanterol powder for inhalation for the treatment of chronic obstructive pulmonary disease
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(7):721-730.
366 times
145 times
DING Xueru
LIU Huimin
HE Xiaodong
LI Hua
LI Zhihao
Fluticasone furoate/umeclidinium/vilanterol
Chronic obstructive pulmonary disease
Markov model
Cost-utility analysis
Pharmacoeconomic
Details
Data mining based on the dosage pattern of Chinese herbal compound patents for the treatment of influenza
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(7):731-742.
300 times
116 times
LI Zhen
HUANG Xiajin
YIN Wenjing
WANG Haifeng
Influenza
Chinese herbal compound
Patent
Association rules
Factor analysis
Cluster analysis
Medication pattern
Details
Investigation and influential factors analysis of knowledge-attitude-practice concerning medication risks among university students in Karamay
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(7):743-752.
300 times
104 times
SHI Yang
CHEN Zhendong
ZHANG Shengzhao
TAN Xue
FAN Dengfeng
CHEN Xiaoli
Medication risk
Knowledge-attitude-practice
Karamay
University students
Influential factors
Rational drug use
Details
Mining and analysis for ocular adverse event signals induced by ALK inhibitors based on FAERS database
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(7):753-759.
333 times
139 times
LUO Banglong
ZHOU Yanping
SU Rui
ALK inhibitors
FAERS database
Ocular adverse events
Signal mining
Pharmacovigilance
Details
Study on the disease burden and prediction of substance use disorder in China based on age-period-cohort model
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(7):760-769.
342 times
97 times
BI Hui
MA Danhua
XU Guili
HUA Yunpeng
XING Liang
Drug abuse
Substance use disorder
Disease burden
Trend analysis
Age-period-cohort model
Details
Ertugliflozin in the treatment of type 2 diabetes mellitus: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(7):778-789.
366 times
127 times
QIN Fang
WU Kunrong
LIU Chengyu
LIU Daihua
Ertugliflozin
Type 2 diabetes mellitus
Efficacy
Safety
Cost-effectiveness
Rapid health technology assessment
Details
上一页
1
2
64
65
66
67
68
69
70
71
72
73
下一页